M4MM
Senate Panel Flags Misleading Cannabis Marketing, Backs Psychedelics Research
LOS ANGELES- The Senate Appropriations Committee released a report accompanying the 2026 agriculture and FDA spending bill that raises concerns over deceptive marketing in the cannabis sector while endorsing expanded federal support for psychedelics research. ...
McConnell Seeks to Close 2018 Hemp “Loophole” in Senate Funding Bill
LOS ANGELES- Senate Republican leader Mitch McConnell is advancing a provision in the FY 2026 agriculture appropriations bill aimed at revising the federal hemp definition to bar products containing any “quantifiable” amount of THC. The action ...
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Senate Panel Flags Misleading Cannabis Marketing, Backs Psychedelics Research
LOS ANGELES- The Senate Appropriations Committee released a report accompanying the 2026 agriculture and FDA spending bill that raises concerns over deceptive marketing in the cannabis sector while endorsing expanded federal support for psychedelics research. ...
McConnell Seeks to Close 2018 Hemp “Loophole” in Senate Funding Bill
LOS ANGELES- Senate Republican leader Mitch McConnell is advancing a provision in the FY 2026 agriculture appropriations bill aimed at revising the federal hemp definition to bar products containing any “quantifiable” amount of THC. The action ...
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Verano Holdings Reports Modest Revenue Growth and Strong Cash Flow in Q3 2023
Verano Holdings Corp. a multi-state cannabis company, disclosed its financial achievements for the third quarter of 2023 on November 8, as per U.S. Generally Accepted Accounting Principles (U.S. GAAP). The company revealed a modest sequential ...
Ascend Wellness Holdings Sees Significant Growth in Q3 2023 Financials
LOS ANGELES- Ascend Wellness Holdings, Inc. an integrated cannabis operator, announced a streak of positive financial outcomes for the third quarter ending September 30, 2023, presenting what is now their sixth consecutive record-breaking revenue quarter. ...
Ohio Becomes 24th State to Legalize Adult-Use Cannabis
COLUMBUS, Ohio— In a defining moment for Ohio, residents went to the polls on Tuesday to cast their votes on Issue 2, a statewide ballot measure that has ushered in a new era of recreational ...
Cybin’s Clinical Trial Indicates Promising Results for Psychedelic Mental Health Treatment
A Canadian biopharmaceutical firm, Cybin, has shared promising results from a clinical trial suggesting the potential of psychedelic compounds in treating mental health issues. The company's focus on developing advanced psychedelic therapeutics has yielded a ...
U.S. States Navigate Psychedelics Reforms Amidst Legalization Efforts
As the United States continues to explore the boundaries of drug policy reform, numerous state legislatures and advocacy groups are engaging in a concerted effort to redefine the legal status of psychedelics. From decriminalization and ...
Colorado Cannabis Business Park Entangled in Legal Battle Over Unpaid Electricity Bills
NEW YORK — A legal tussle over a six-figure electricity bill has emerged between the owners of Area 420, a Colorado cannabis business park, and one of its tenants, as reported by NBC. The dispute, ...
Florida Medical Cannabis Company Challenges State Over Licensing Fee Spike
NEW YORK — Sanctuary Cannabis, a player in Florida's medical cannabis industry, has initiated legal proceedings against the state, challenging a dramatic rise in biennial licensing fees. Under Governor Ron DeSantis' administration, the fees escalated ...
Ohio’s Cannabis Industry Eyes Adult-Use Legalization with Hope and Vigilance
LOS ANGELES- Ohio’s medical cannabis industry is looking toward the upcoming ballot with a mix of hope and caution as Issue 2, which would legalize adult-use cannabis, approaches a statewide vote. Operators in the sector ...
Ohio Decides On Adult-Use Legalization of Cannabis
CLEVELAND, Ohio – In Ohio, a momentous decision looms large on the horizon, transcending the scope of mere recreational cannabis decriminalization. The state's citizens are poised to exercise their voting rights on November 7, deliberating ...
Organigram Stock Rallies On $124.6 Million Investment from British American Tobacco Subsidiary
TORONTO- In a significant financial development, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has secured a substantial investment of $124.6 million from BT DE Investments Inc., a subsidiary of British American Tobacco (NYSE: BTI). This ...
Alabama Medical Cannabis Commission Sets December Goal for Licensing Amid Legal Challenges
Alabama — After navigating through a series of legal hurdles and procedural delays, the Alabama Medical Cannabis Commission (AMCC) is now targeting December to finalize industry licenses, a move that its chairman describes as part ...
Kansas City Cannabis Workers Vote to Unionize, Joining Teamsters Local 955
LOS ANGELES— Employees at Home State Dispensary in Kansas City have made a landmark decision to unionize, becoming the first group of cannabis workers in the metro area to do so. The budtenders and inventory ...
MindMed Projects Operational Continuity into 2026 Amid Advancements in LSD-Based Anxiety Treatment
NEW YORK — Mind Medicine Inc. (MindMed), a biopharmaceutical company leading the charge in psychedelic drug development, has assured stakeholders of its financial viability well into 2026. This assurance comes even as the company, which currently ...
Optimi Health Secures CAD$1 Million in Non-Dilutive Debt Financing
TORONTO— Optimi Health Corp., a Canadian pioneer in psychedelic substance research and production, has successfully secured a non-dilutive Debt Financing Agreement (DFA) for a sum of CAD$1,000,000. This loan, provided by an arm's length party, ...
Senate Advances Bill Permitting VA Doctors to Recommend Cannabis to Veterans
WASHINGTON, D.C. — In a significant policy shift, the U.S. Senate has passed a bill that, among other directives, authorizes Department of Veterans Affairs (VA) physicians to recommend cannabis to veterans for medical purposes. This ...
